key: cord-1007743-fjijfyty
authors: Balakumar, Balasubramanian; Nandra, Rajpal S.; Woffenden, Hugo; Atkin, Benjamin; Mahmood, Ansar; Cooper, George; Cooper, Julian; Hindle, Paul
title: Mortality risk of surgically managing orthopaedic trauma during the COVID-19 pandemic
date: 2021-05-24
journal: Bone Jt Open
DOI: 10.1302/2633-1462.25.bjo-2020-0189.r1
sha: 4f02a7018247ff3c35f83961e05793cce65259ca
doc_id: 1007743
cord_uid: fjijfyty

AIMS: It is imperative to understand the risks of operating on urgent cases during the COVID-19 (SARS-Cov-2 virus) pandemic for clinical decision-making and medical resource planning. The primary aim was to determine the mortality risk and associated variables when operating on urgent cases during the COVID-19 pandemic. The secondary objective was to assess differences in the outcome of patients treated between sites treating COVID-19 and a separate surgical site. METHODS: The primary outcome measure was 30-day mortality. Secondary measures included complications of surgery, COVID-19 infection, and length of stay. Multiple variables were assessed for their contribution to the 30-day mortality. In total, 433 patients were included with a mean age of 65 years; 45% were male, and 90% were Caucasian. RESULTS: Overall mortality was 7.6% for all patients and 15.9% for femoral neck fractures. The mortality rate increased from 7.5% to 44.2% in patients with fracture neck of femur and a COVID-19 infection. The COVID-19 rate in the 30-day postoperative period was 11%. COVID-19 infection, age, and Charlson Comorbidity Index were independent risk factor for mortality. CONCLUSION: There was a significant risk of contracting COVID-19 due to being admitted to hospital. Using a site which was not treating COVID-19 respiratory patients for surgery did not identify a difference with respect to mortality, nosocomial COVID-19 infection, or length of stay. The COVID-19 pandemic significantly increases perioperative mortality risk in patients with fractured neck of femora but patients with other injuries were not at increased risk. Cite this article: Bone Jt Open 2021;2(5):330–336.

The pneumonitis triggered by SARS-CoV-2, responsible for the COVID-19 pandemic, can progress to acute respiratory distress syndrome. 1, 2 The COVIDSurg Collaborative reported 30-day postoperative mortality in COVID-19-positive patients as 23.8%. 3 Studies reporting the 30-day mortality of patients with fractured neck of femur (NOF) and COVID-19 infection reported mortality rates of 30.5% to 35.5% and demonstrated that COVID-19 infection was an independent risk factor for mortality. 4, 5 Being one of the busiest managing COVID-19 ventilatory cases across Europe (University Hospitals Birmingham NHS Foundation Trust), the trust moved to an emergency plan to deal with the expected surge in COVID-19 patients in March 2020. Services were reconfigured to prioritize the treatment of viral pneumonia with a focus on maximizing intensive care capacity. 6 The orthopaedic service was reorganized so that the minimum number of patients were admitted to the major trauma centre (MTC) and district general hospital (DGH, a secondary care facility with diagnostic and therapeutic facilities); the majority of the cases were redirected to the local elective surgery site (ESS). The MTC continued as the major trauma centre for the region and also dealt with cases deemed medically unfit for the ESS. Even though changes were implemented to follow the British Orthopaedic Association (BOA) guidelines, 7 with an emphasis on using nonoperative management where possible, 6 this structure allowed for the timely surgical management of orthopaedic trauma.

This study primarily aimed to distinguish the mortality risk of undergoing urgent orthopaedic surgery during the first wave of COVID-19 pandemic in the UK. The secondary objective was to assess if there was a difference in outcome of surgery between sites, by diverting the orthopaedic trauma cases to an ESS to free up beds in a busy MTC and DGH. Our primary outcomes were 30-day mortality, and secondary measures were COVID-19 infection rate and length of stay (LOS).

A prospectively maintained trauma database identified all trauma and orthopaedic patients that were admitted and required surgery between 26 March and 20 May 2020 emergency plan during the first lockdown. The study was approved by the institutional review board. Trust audit policies were adhered to for this study and no patients were directly contacted. Inclusion and exclusion criteria. Patients aged 18 years or over treated surgically across the trust were included. Spinal conditions and hand trauma treated by separate services were excluded. Trauma pathway. Care was diverted away from DGH early in the primary stage of the pandemic due to capacity issues. The ESS is normally a specialist elective orthopaedic hospital (Royal Orthopaedic Hospital NHS Foundation Trust) which was only used for urgent surgery throughout the pandemic; it did not play a role in admitting patients who required treatment for non-orthopaedic respiratory COVID-19. The patient flow is shown in the Figure 1 .

Electronic patient records (EPR) was used to collect patient demographics such as: age; sex; ethnicity; BMI; dates of admission, surgery and discharge; comorbidities and Charlson Comorbidity Index (CCI); 8 American Society of Anesthesiologists (ASA) Classification; 9 and Clinical Frailty Scale (CFS). 10 The following injury and treatment factors were recorded: surgery performed; open or closed injury; mechanism, fracture type (NOF vs other trauma). Nottingham Hip Fracture Scores (NHFS) 11 were recorded for femoral neck fractures. All swab results for COVID-19 taken pre-and post-surgery were collected. Statistical analysis. R software (version 4.0.2; R Foundation for Statistical Computing, Austria) with a pre-determined significance level of 0.05 was used. Continuous variables underwent a Shapiro-Wilk test for normality with subsequent univariate analysis with the outcome of interest (response), alive or dead within 30 days of surgery. Individual comparisons were made using the chi-squared test for categorical data and independent t-test for continuous data except where normality could not be assumed where a Mann-Whitney U test was used. To explore the influence of risk factors multiple logistic regression modelling was performed. The following variables were considered for inclusion in the modelling: age; sex; ethnicity; ASA; BMI; CFS; hip fracture diagnosis; hospital site; time to surgery; number of procedures; CCI;, preoperative COVID-19 status; and final COVID-19 status.

Two multiple logistic regression models were developed. Model 1 was based on variables known postoperatively, including the final COVID-19 status. Model 2 included variables known preoperatively to reflect risk assessment in preoperative patients. Model selection was performed on a training subset (60%) of the data, and the final, minimal adequate, models cross-validated against the remaining data. Models were assessed by receiver operating curve (ROC) analysis, Hosmer-Lemeshow goodness of fit, 12 and McFadden R 2 . 13 The final models were refit against the whole dataset.

The final minimal adequate model 1 had age, sex, ethnicity, CFS, NOF diagnosis, treating hospital, CCI, and final COVID-19 status as predictors (Table I) . Sex, ethnicity, and CFS were individually not significant in the model. The final model had excellent discrimination on ROC curve analysis (area under curve (AUC) 0.958, 95% confidence interval (CI) 0.930 to 0.986), and excellent calibration (McFadden R 2 0.5429; p = 0.517, Hosmer-Lemeshow test). Model 2 had the same predictors as model 1 in the final model, except that COVID-19 status was included as known preoperatively and included suspected cases. This model also had excellent discrimination (AUC 0.935, 95% CI 0.905 to 0.965), and was well calibrated (McFadden R 2 0.4504; p = 0.9787, Hosmer-Lemeshow test).

The study included 433 patients (Table II) . CFS was recorded in 397 (93%) patients. The majority of cases were treated at the ESS (n = 308,72%), with the MTC treating 96 (23%). Type of injuries and length of stay. Most of patients sustained low-energy injuries (n = 276; 64%), with the majority being femoral neck fractures (n = 189; 68.5%). There were 429 patients with 456 injuries, including 16 polytrauma. The cases are detailed in Table III . The majority of the patients had surgery within 24 hours of injury (n = 245,57%) with a median LOS of six days (interquartile range (IQR) 2 to 11). This increased for patients with a fractured neck of femur (nine vs three days, p < 0.001). Overall mortality data. Overall, there were 33 deaths; the 30-day mortality rate was 7.6% (n = 33) (Table IV) , with the majority of deaths occurring in patients who were treated for a fractured NOF (30/33, 90.9% of deaths). The 30-day mortality rate during the previous year for the same period was 2.7% with 8.1% mortality for NOFs and 1% for other trauma (259 cases with 62 NOFs in 2019). Mortality data for NOFs. The mortality rates for patients with femoral neck fractures are shown in Table IV . The data are broken down by the hospital in which they were treated and the neck of femur patients are separated into whether they had a COVID-19 infection (pre-or postoperatively). In the 30 (15.5%) patients who died following treatment for a fractured NOF, nine died in hospital and 21 died following discharge. Mortality in other trauma cases. The two patients who died and did not have a NOF were both COVID-19positive; one was classed as moderately frail and had a prosthetic hip dislocation manipulated under anaesthesia, while the other was an 86-year-old male, classed as mildly frail who underwent reverse total shoulder arthroplasty. Comparison of NOF vs other trauma mortality. The mortality rate was significantly higher in patients with a femoral neck fracture compared to the those without (15.8% vs 0.83%, p = 0.001, chi-squared test). Table V shows the sub-group analysis used to investigate patient and treatment factors that influenced mortality. Increased age and higher estimates on validated prognostic tools were significantly different in these groups (ASA, NHFS, CCI, and CFS). Absent data. BMI and time to surgery had missing data , 23% and 21% respectively. Hospital site influenced proportion of missing data in these fields and therefore not included in the modelling. CFS was missing in 32 (10.4%) of the ESS cases; these were imputed with the median CFS for the site. CFS was grouped into those with CFS 7 to 9 and those less than 7. ASA and number of procedures did not significantly reduce deviance and were not included in the final models. (Table VI) ; MTC n = 4 to a total of n = 8 (4 + 4; 4% to 8%), DGH n = 2 to n = 8 (2 + 6; 8% to 25%), and ESS n = 3 to n = 40 (3 + 37; 1% to 13%). In total, 37 of the positive results had femoral neck fractures, three periprosthetic fractures, three prosthetic hip dislocations, one periprosthetic hip infection, one proximal humerus fracture, and one abscess.

This study is the largest series looking at surgically managed orthopaedic trauma during the first wave of COVID-19 pandemic. In patients without a NOF, the mortality rate was 0.7% compared to 1% the previous year, which is comparable to 0.95% in a pre-COVID-19 trauma series. 14 The mortality risk to patients without a proximal femoral fracture was no greater than in the pre-pandemic period, even if they were to acquire COVID-19 infection. This information is invaluable when counselling patients of the risks of urgent surgery when they cannot wait for negative swabs and two weeks of isolation, as has been suggested for elective surgery. The majority of deaths were in femoral neck fractures and the overall mortality rate was higher than for the same period in 2019 when compared to the National Hip Fracture Database (NHFD) data (15.9% vs 6.1%). 15 Femoral neck fractures that were COVID-19-negative had a lower mortality than the previous year at the MTC (4.8% vs 8.4%), and were comparable to the national average at the ESS. 15 COVID-19 infection and mortality were found to be related to age and frailty; this could represent that those who died were already at a higher risk of mortality. 16 Our data permits a direct comparison between patients treated under the same conditions with and without COVID-19. We found a higher overall mortality rate in COVID-19 patients than that reported by the COVIDSurg collaborative; 3 this is likely due to the strong skew towards older age in our study, particularly from patients sustaining femoral neck fractures. In the COVIDSurg study cohort, 50% of patients were aged 70 years or over; in our study; 86% of COVID-19-positive patients were aged over 70 years. Our data corroborates that a COVID-19 infection was an independent risk factor for mortality in this group. 4, 5 Increased age is an accepted risk factor for increased morbidity and mortality, 17 with the risk of contracting COVID-19 and mortality being associated with ethnicity, increased BMI, diabetes, and hypertension. Our analysis demonstrated that age and CCI were independent risk factors, but found the other conditions identified previously were not significant.

We found that CFS was not significant as a predictor in the modelling but it did add to the model performance, and was retained. By contrast, Hewitt et al 18 found that CFS 7 to 9 was a significant predictor of seven-day mortality in 1,564 heterogenous patients. In that study, lesser frailty was not a significant predictor of seven-day mortality, though there was an effect on time to mortality. In our study, relatively few patients (13/430, 3.0%) fell into that severe frailty group, which may account for the inability of our model to detect significance for CFS. This is important if health services need to utilize a differentiating score for rationalizing healthcare provision in any subsequent waves of the pandemic.

Concerns have been raised about potential harm to non-COVID-19 patients, such as delaying cancer treatment, due to the national prioritization to deal with COVID-19. An unforeseen finding was the relatively higher mortality rate in patients with femoral neck fractures operated on at the DGH. These patients were all operated on at the end of March 2020, just prior to the hospital closing to orthopaedic trauma due to the pressures to treat patients with COVID-19 pneumonia. While these patients did not die directly from COVID-19, it is likely that their mortality was contributed to by the requirement to divert services to the treatment of COVID-19. One contributing factor to this increased mortality rate may have been selection bias generated by the transfer process between DGH and the ESS. It was initially difficult for patients with multiple comorbidities to meet the criteria required for transfer. These criteria were relaxed as the COVID-19 pandemic progressed.

We found a decreased LOS in femoral neck fracture patients compared to the NHFD data from 2019 (nine vs 17 days), and also in contrast to the London, UK, pandemic experience. 5, 18 In preparation for, and during, the surge, the trust promoted a culture of facilitating discharge of patients to decrease the risk of acquiring COVID-19 and to provide care for new admissions. This was supported by trust policies of daily consultant reviews to ensure prompt decision-making and that barriers to treatment and discharge were addressed. Despite a number of patients dying after discharge, there was no increase in mortality, except where patients contracted COVID-19. Data was unavailable on any complications other than mortality that occurred in the community that did not require hospital treatment.

The initial BOA guidance was to reduce the surgical management of orthopaedic trauma. 19 While this, in part, owed to concerns over surgical capacity it was also due to the uncertain risk to patients which this study has helped to quantify. The findings from our study will assist in risk-assessing patients for surgery during subsequent surges in COVID-19, including the preoperative model, which can be used to calculate mortality risk. 20 The risk of being admitted with an undetected infection is estimated at one in 7,000. 21 Our study highlights the risk of nosocomial infection for COVID-19 in those requiring urgent surgery who need to be admitted without prior isolation. These data support the segregation of urgent and elective surgery.

During the COVID-19 surge, there were concerns over how to treat patients who were negative or suspected of COVID-19 when they went for surgery; initially, patients were not tested unless they had symptoms, and this moved to full screening as more testing became available. 22 The rates of acquiring a COVID-19 infection postoperatively was 11% for those who initially had had a negative test, 9.4% in those who had not been suspected and so were not swabbed, and 25% in those who had tested negative despite displaying symptoms consistent with COVID-19. As it is unlikely that patients had an undetected infection, it is likely that postoperative infections were nosocomial. The group that were not suspected had a postoperative infection rate of 10%, which is much higher than the 0.3% reported in the community, 23 suggesting that they acquired their infection while in hospital. Patients were not isolated unless they became symptomatic, risking patient-to-patient transfer. This may have increased the rate of nosocomial infection, and will need to be considered when planning resources for future surges.

Patients were presenting to the MTC with nonrespiratory conditions and were subsequently identified as having COVID-19 infections, as well as their presenting condition; these included, but were not limited to, orthopaedic patients.

In this study, there was no significant difference in the mortality or COVID-19 postoperative infection rate when comparing a site acutely dealing with COVID-19 patients and the site that was not. There was a significant difference in these two measures between these two hospitals, and the DGH that had to close to orthopaedic trauma. The use of a separate site to perform the majority of cases proved invaluable to continuing patient flow and contributed to allowing the MTC to function as the major trauma centre. These data have implications on planning services for a second wave.

The main limitation of this paper was the heterogeneity of the population and the evolving nature of policies within the trust, but this is also a pragmatic review of how the busiest hospital in Europe for COVID-19 continued to provide urgent orthopaedic care during unprecedented times. This was not a prospective study and is therefore limited by the data that could be obtained from electronic records.

This paper has demonstrated a number of key lessons to inform clinicians and patients on the risks of operating during the COVID-19, principally that any increase in mortality appears limited to femoral neck fracture patients and is related to age, coexisting medical conditions, and contracting COVID-19. The majority of urgent orthopaedic surgery can be carried out with little increase in risk to patients. There are also important messages for strategic planning for any subsequent surges with regards the utility using separate sites for surgery away from hospitals focused on treating COVID-19, the risks of hospital acquired infections and the risk of prioritising one group of patients over another. The majority of urgent orthopaedic patients were at no increased risk of mortality.

-There was no increase in mortliaty in those operated on who did not have a fractured neck of femur. There is therefore no need to rationalise othoapaedic surgery on this basis. -The risk of nosocomial infection needs to be taken into account when planning services for any future surges in the COVID-19 pandemic.

Follow B. Balakumar @balakumar_dr Follow R. S. Nandra @rajpalnandra Follow A. Mahmood @Trauma_Fixer

COVID-19 infection: origin, transmission, and characteristics of human coronaviruses

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

IMPACT-Scot report on COVID-19 and hip fractures

The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures

Reflections from London's Level-1 Major Trauma Centres during the COVID crisis

Change in practice due to COVID-19 -Early experiences of a United Kingdom district general hospital in trauma & orthopaedics

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

American Society of Anesthesiologists Classification

A global clinical measure of fitness and frailty in elderly people

Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery

A generalized Hosmer-Lemeshow goodnessof-fit test for multinomial logistic regression models

Conditional Logit Analysis of Qualitative Choice Behavior. Frontiers in Econometrics

Incidence and causes of mortality following acute orthopaedic and trauma admissions

Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The effect of frailty on survival in patients with COVID-19 (cope): a multicentre, European, observational cohort study

British Orthopaedic Association. Management of patients with urgent orthopaedic conditions and trauma during the coronavirus pandemic. Boa. ac. uk

Reinstating elective orthopaedic surgery in the age of COVID-19

The theoretical mortality risk of an asymptomatic patient with a negative SARS-CoV-2 test developing COVID-19 following elective orthopaedic surgery

Orthopaedic surgery in a time of COVID-19

Surgeon Lieutenant, Medical officer, Royal Navy; Foundation Doctor B. Atkin, MBChB (Hons), Medical Officer, Royal Navy; Foundation Doctor A. Mahmood, MB, ChB, MRCS, FRCS (Tr&Orth)

Carried out statistcal assessment of results, Prepared the manuscript. H. Woffenden: Collected the data, Reviewed the manuscript. B. Atkin: Collected the data, Reviewed the manuscript. A. Mahmood: Undertool co-ordination

Undertook second site data collection, Prepared the manuscript

Prepared the manuscript. P. Hindle: Conceptualized the study, Collected the data

The authors would like to directly thank Miss Caroline Plant, Mr Krishnakumar Subbaraman, Mr Robert Jordan, and Dr Deborah Mortiboy for their assistance in data collection. We would also like to acknowledge the collaborative work of the staff within the trauma and orthoapedic departments of University Hopsitals Birmingham NHS Foundation Trust and the Royal Orthopaedic Hospital NHS Foundation Trust for all of their work during the COVID-19 pandemic.

No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

A. Mahmood reports consultancy for Stryker CMF, which is unrelated to this article.